<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Byrne McFadden | Activity</title>
	<link>https://www.catswannabecats.com/members/epoxymodem6/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/epoxymodem6/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Byrne McFadden.</description>
	<lastBuildDate>Tue, 16 Jun 2026 15:30:45 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">bf6e8f6a97e5bcbb9cfc17b6e195ccfb</guid>
				<title>Byrne McFadden posted an update: BACKGROUND Intracanal medicaments can be used in various [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/26342/</link>
				<pubDate>Tue, 10 Jun 2025 10:20:57 -0400</pubDate>

									<content:encoded><![CDATA[<p>BACKGROUND Intracanal medicaments can be used in various endodontic conditions including multiple visit endodontics after trauma or in regenerative endodontics. These medicaments should be removed from the root canal before the placement of the filling or repair material. The aim of the present study was to evaluate the effect of prior calcium&hellip;<span class="activity-read-more" id="activity-read-more-26342"><a href="https://www.catswannabecats.com/activity/p/26342/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">47c1f8031bed974234b5d7c21bb652f6</guid>
				<title>Byrne McFadden posted an update: A trial of a carbonic anhydrase inhibitor was frustrated by [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23756/</link>
				<pubDate>Sun, 08 Jun 2025 10:29:03 -0400</pubDate>

									<content:encoded><![CDATA[<p>A trial of a carbonic anhydrase inhibitor was frustrated by coexisting corneal edema associated with the condition.Acne vulgaris is a very common pilosebaceous inflammatory disease occurring primarily on the face and also rare on the upper arms, trunk, and back, which is caused by Propionibacterium, Staphylococcus, Corynebacterium, and other&hellip;<span class="activity-read-more" id="activity-read-more-23756"><a href="https://www.catswannabecats.com/activity/p/23756/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">61771b563c3c4616e59f1934c27d0cb6</guid>
				<title>Byrne McFadden posted an update: Moreover, the dual-scale vaccine is synergized with an [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/10568/</link>
				<pubDate>Sun, 01 Jun 2025 01:46:48 -0400</pubDate>

									<content:encoded><![CDATA[<p>Moreover, the dual-scale vaccine is synergized with an immune checkpoint inhibitor to inhibit tumor growth in tumor-bearing mice. The findings suggest that the MSR is a novel platform for delivering nanoparticle vaccines for the enhancement of cancer immunotherapy. Ultrasonic bioreactors have been used for in vitro experimentation to study&hellip;<span class="activity-read-more" id="activity-read-more-10568"><a href="https://www.catswannabecats.com/activity/p/10568/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">396c66ddbd3c14fcd6d964f5ca3336ae</guid>
				<title>Byrne McFadden became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/9480/</link>
				<pubDate>Sat, 31 May 2025 22:44:51 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>